Activated PI3K/AKT confers resistance to trastuzumab but not lapatinib

被引：6
|
作者：
Lisa Hutchinson
机构：
来源：
Nature Reviews Clinical Oncology | 2010年 / 7卷 / 8期
关键词：
D O I：
10.1038/nrclinonc.2010.113
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：424 / 424
相关论文
共 50 条
  • [31] PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs)
    Jian Li
    Yunzhi Dang
    Jing Gao
    Yanyan Li
    Jianling Zou
    Lin Shen
    Medical Oncology, 2015, 32
  • [32] Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
    Yong Yook Lee
    Hwang-Phill Kim
    Min Jueng Kang
    Byoung-Kyu Cho
    Sae-Won Han
    Tae-You Kim
    Eugene C Yi
    Experimental & Molecular Medicine, 2013, 45 : e64 - e64
  • [33] Remifentanil preconditioning confers cardioprotection via the JAK/STAT but not PI3K/Akt pathway in rats
    Qiao, Shigang
    Liu, Yanan
    Wang, Tingting
    Mao, Xiaowen
    Wong, Gordon T.
    Xia, Zhengyuan
    Irwin, Michael G.
    FASEB JOURNAL, 2011, 25
  • [34] Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
    Lee, Yong Yook
    Kim, Hwang-Phill
    Kang, Min Jueng
    Cho, Byoung-Kyu
    Han, Sae-Won
    Kim, Tae-You
    Yi, Eugene C.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2013, 45 : e64 - e64
  • [35] Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
    Cedric Leroy
    Pedro Ramos
    Karen Cornille
    Debora Bonenfant
    Christine Fritsch
    Hans Voshol
    Mohamed Bentires-Alj
    Breast Cancer Research, 18
  • [36] The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma
    Wang, Lei
    Lin, Na
    Li, Yan
    ONCOLOGY REPORTS, 2019, 41 (03) : 1678 - 1690
  • [37] Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
    Leroy, Cedric
    Ramos, Pedro
    Cornille, Karen
    Bonenfant, Debora
    Fritsch, Christine
    Voshol, Hans
    Bentires-Alj, Mohamed
    BREAST CANCER RESEARCH, 2016, 18
  • [38] The Treatment of Activated PI3Kδ Syndrome
    Coulter, Tanya I.
    Cant, Andrew J.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [39] PI3K/Akt Pathway Mutations in Retinoblastoma
    Cohen, Yoram
    Merhavi-Shoham, Efrat
    Avraham-Lubin, Bat Chen R.
    Savetsky, Michael
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) : 5054 - 5056
  • [40] PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
    Liu, Rui
    Chen, Youwen
    Liu, Guangzhi
    Li, Chenxi
    Song, Yurong
    Cao, Zhiwen
    Li, Wen
    Hu, Jinghong
    Lu, Cheng
    Liu, Yuanyan
    CELL DEATH & DISEASE, 2020, 11 (09)
12345